Steve Song
A report by the General Accounting Office concludes that current patent law discourages drug companies from developing new drugs by allowing them to make excessive profits through minor changes to existing pharmaceuticals.
patents ipr pharmaceuticals innovation
Would you like to comment?
Join Diigo for a free account, or sign in if you are already a member.